These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38466424)
1. Alpha-fetoprotein producing endometrioid carcinoma arising in an adenomyoma of the uterus. Oyama Y; Kusaba T; Takao K; Obata E; Yano M; Kawamura K; Nishida H; Daa T Med Mol Morphol; 2024 Sep; 57(3):218-225. PubMed ID: 38466424 [TBL] [Abstract][Full Text] [Related]
2. Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid Adenomyoma (APA) From its Benign Mimics. Bui CM; Azimpouran M; Balzer B; Maluf H; Medeiros F Int J Gynecol Pathol; 2024 Nov; 43(6):586-594. PubMed ID: 38833724 [TBL] [Abstract][Full Text] [Related]
3. A case of endometrial carcinoma arising in a 36-year-old woman with uterine atypical polypoid adenomyoma (APA). Bakalianou K; Salakos N; Iavazzo C; Paltoglou G; Papadias K; Kondi-Pafiti A Eur J Gynaecol Oncol; 2008; 29(3):298-9. PubMed ID: 18592801 [TBL] [Abstract][Full Text] [Related]
4. Atypical polypoid adenomyoma of the endometrium: diagnosis and treatment. A case report. Domeniconi L; Amadori A; Maniglio P; Saragoni L Pathologica; 2020 Dec; 112(4):214-218. PubMed ID: 33393525 [TBL] [Abstract][Full Text] [Related]
5. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus. Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177 [TBL] [Abstract][Full Text] [Related]
6. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma. Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673 [TBL] [Abstract][Full Text] [Related]
7. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling. Worrell HI; Sciallis AP; Skala SL Histopathology; 2021 Jul; 79(1):96-105. PubMed ID: 33459390 [TBL] [Abstract][Full Text] [Related]
8. Hepatoid carcinoma of the uterus that collided with carcinosarcoma. Takahashi Y; Inoue T Pathol Int; 2003 May; 53(5):323-6. PubMed ID: 12713569 [TBL] [Abstract][Full Text] [Related]
9. Atypical polypoid adenomyoma of the uterus: A reappraisal of the clinicopathological and immunohistochemical features. Lu B; Yu M; Shi H; Chen Q Pathol Res Pract; 2019 Apr; 215(4):766-771. PubMed ID: 30661903 [TBL] [Abstract][Full Text] [Related]
10. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon. Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830 [TBL] [Abstract][Full Text] [Related]
12. α-fetoprotein produced by endometrioid adenocarcinoma of uterus. Akhavan A; Karimi Zarchi M; Akhavan Tafti M; Navabii H BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22736779 [TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium. Toyoda H; Hirai T; Ishii E Pathol Int; 2000 Oct; 50(10):847-52. PubMed ID: 11107058 [TBL] [Abstract][Full Text] [Related]
14. Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein. Maida Y; Kyo S; Takakura M; Kanaya T; Inoue M Gynecol Oncol; 1998 Oct; 71(1):133-6. PubMed ID: 9784334 [TBL] [Abstract][Full Text] [Related]
15. Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac Markers. Mills AM; Jenkins TM; Dibbern ME; Atkins KA; Ring KL Am J Surg Pathol; 2024 Jul; 48(7):790-802. PubMed ID: 38651612 [TBL] [Abstract][Full Text] [Related]
16. A rare case of concomitant endometrioid adenocarcinoma arising from uterine adenomyosis and clear cell carcinoma arising from parametrial deep endometriosis. Zhou C; Luo X; Tang M; Luo F; Liao Z BMC Womens Health; 2024 Aug; 24(1):440. PubMed ID: 39090585 [TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature. Tran TA; Ortiz HB; Holloway RW; Bigsby GE; Finkler NJ Int J Gynecol Pathol; 2007 Jan; 26(1):66-70. PubMed ID: 17197899 [TBL] [Abstract][Full Text] [Related]
18. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis. Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579 [TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review. Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751 [TBL] [Abstract][Full Text] [Related]
20. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]